AI Eases Hospital‑Insurer Bills
AI systems are being used to resolve longstanding disputes between U.S. hospitals and insurers over medical‑bill responsibility, automating reviews and reducing denials to speed settlements, reported. That workflow automation shortens procurement friction and could compress device sales cycles tied to contested claims.
[Reuters reported]msn.com on March 12 that hospitals are deploying AI to strengthen documentation for higher reimbursements while insurers use AI to scrutinize medical‑necessity, turning billing disputes into an AI‑versus‑AI contest. A 2025 Experian Health survey found 73% of providers saw claims denials increase and 38% said denials occur on at least 10% of claims, pressuring revenue cycles.hfma.org Newsweek cited American Hospital Association data showing denials rose more than 20% for private commercial claims and nearly 56% for Medicare Advantage between 2022 and 2023.newsweek.com The vendor landscape has been volatile: Olive AI famously ceased operations on Oct. 31, 2023, after aggressive expansion into revenue‑cycle automation.hfma.org At the same time, health systems are buying denial‑reduction tools from established players such as Experian Health and from startups highlighted in an AHA case study on Ailevate.experian.com Industry groups warn reimbursement delays slow device adoption, with the Medical Device Manufacturers Association noting timely payment is essential to patient access and market uptake.medicaldevices.org CMS’s Jan. 1, 2025 transitional pass‑through payments for Medtronic’s Symplicity Spyral and Recor’s Paradise renal‑denervation systems show how a reimbursement decision can reduce cost barriers and accelerate commercial rollout.fiercebiotech.com
